Inventor
VIEIRA MICHAEL L
US17 patents
⚠️ This page may combine multiple inventors who share the name “VIEIRA MICHAEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUPERNUS PHARMACEUTICALS INC
12 patentsUS10265319B2Apr 23, 2019
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC4 citations83
US9662338B2May 30, 2017
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC5 citations83
US9358204B2Jun 7, 2016
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC7 citations83
US11077114B2Aug 3, 2021
Stabilized formulations of CNS compounds
SUPERNUS PHARMACEUTICALS INC1 citations72
US10149853B2Dec 11, 2018
Stabilized formulations of CNS compounds
SUPERNUS PHARMACEUTICALS INC2 citations72
US9603853B2Mar 28, 2017
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC3 citations72
US10314790B2Jun 11, 2019
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US9622983B2Apr 18, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US9555004B2Jan 31, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US9549940B2Jan 24, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US8992989B2Mar 31, 2015
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US8877248B1Nov 4, 2014
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
LIANG LIKAN
4 patentsUS8298580B2Oct 30, 2012
Sustained-release formulations of topiramate
LIANG LIKAN12 citations92
US8663683B2Mar 4, 2014
Sustained-release formulations of topiramate
LIANG LIKAN4 citations83
US8889191B2Nov 18, 2014
Sustained-release formulations of topiramate
LIANG LIKAN1 citations62
US8298576B2Oct 30, 2012
Sustained-release formulations of topiramate
LIANG LIKAN1 citations62